Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › LA › Columbia › NPI 1306865761
Hospital

Hospital Service District No. 1 of Caldwell Parish

Hospital Service District No. 1 of Caldwell Parish was paid $4.09M by Medicaid between Jan 2018 and Dec 2024, across 112 billing codes. Its largest line is 99283, emergency room visit (moderate) — 21% of everything it billed.

33Billing provider infoHOSPITAL SERVICE DISTRICT NO. 1 OF CALDWELL PARISH
COLUMBIA, LA 71418
33aNPI1306865761assigned 07/18/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.09M
24GClaims143,439
24DCodes billed112
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Louisiana

Rank by total paid#54 of 96
Median peer was paid$5.17M
This provider vs. median0.8×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201820,112$599K
201920,140$439K
202013,149$408K
202120,468$677K
202229,526$919K
202324,222$685K
2024incomplete15,822$361K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 21% 14,614 8,836 $876K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 21% 9,124 6,144 $839K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 19% 5,329 3,443 $788K
G0378 Hospital observation service, per hour 4.5% 769 520 $185K
71046 Radiologic examination, chest; 2 views 2.8% 2,284 1,933 $114K
80050 General health panel 2.7% 2,621 2,455 $109K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2.0% 1,077 945 $80K
80053 Comprehensive metabolic panel 1.8% 11,212 7,899 $75K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.5% 11,933 8,636 $62K
71045 Radiologic examination, chest; single view 1.4% 1,647 1,342 $59K
70450 Computed tomography, head or brain; without contrast material 1.4% 188 167 $57K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.4% 1,874 1,506 $56K
100 more codes
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.3% 2,884 $52K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1.2% 2,090 $51K
70220 1.1% 604 $46K
36415 Collection of venous blood by venipuncture 1.1% 20,897 $45K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 8,960 $39K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 3,127 $38K
80061 Lipid panel <1% 2,893 $33K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 642 $32K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,666 $32K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 214 $26K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 1,397 $26K
82607 <1% 1,961 $25K
74022 <1% 308 $25K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 61 $22K
96375 Therapeutic injection; each additional sequential IV push <1% 472 $21K
81001 <1% 8,839 $21K
83880 <1% 729 $19K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 14 $16K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,167 $15K
83036 Hemoglobin; glycosylated (A1C) <1% 1,763 $14K
83735 <1% 2,530 $14K
87428 <1% 678 $13K
87088 <1% 1,697 $12K
83525 <1% 1,122 $11K
84443 Thyroid stimulating hormone (TSH) <1% 928 $10K
84484 <1% 1,219 $10K
84481 <1% 685 $8K
83690 <1% 1,424 $7K
0002A <1% 236 $7K
84439 <1% 819 $6K
0001A <1% 176 $5K
99220 <1% 87 $5K
86376 <1% 379 $5K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 17 $5K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 14 $4K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 150 $4K
72100 <1% 70 $4K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 28 $4K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 299 $4K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 13 $3K
93041 <1% 1,171 $3K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 42 $3K
86308 <1% 539 $3K
J7120 Ringers lactate infusion, up to 1000 cc <1% 113 $3K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 538 $2K
99223 Prolong inpt eval add15 m <1% 43 $2K
96361 Intravenous infusion, hydration; each additional hour <1% 70 $2K
J1650 Injection, enoxaparin sodium, 10 mg <1% 27 $2K
82746 <1% 179 $2K
82150 <1% 396 $2K
74019 <1% 33 $2K
81025 <1% 280 $2K
96376 <1% 59 $2K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 13 $2K
87807 <1% 112 $2K
99222 Initial hospital care, per day, moderate complexity <1% 44 $1K
99233 Hospital visit by a doctor, follow-up day (complex) <1% 91 $1K
99218 <1% 48 $1K
93017 <1% 15 $1K
J7030 Infusion, normal saline solution , 1000 cc <1% 59 $1K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 26 $916.65
83605 <1% 112 $833.04
89220 <1% 63 $737.77
86140 <1% 214 $701.95
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 312 $667.84
0003A <1% 13 $654.64
82670 <1% 27 $642.62
87186 <1% 75 $582.93
87077 <1% 75 $544.65
82043 <1% 103 $508.64
81000 <1% 158 $406.02
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 77 $405.84
84100 <1% 103 $388.68
81003 <1% 184 $351.60
G0238 Therapeutic procedures to improve respiratory function, other than described by g0237, one on one, face to face, per 15 minutes (includes monitoring) <1% 33 $325.04
86665 <1% 16 $271.79
94760 <1% 540 $267.32
85651 <1% 69 $230.58
86664 <1% 16 $229.09
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg <1% 14 $226.94
83615 <1% 44 $223.48
86663 <1% 16 $196.58
85027 <1% 30 $172.32
86337 <1% 15 $170.76
C9113 Injection, pantoprazole sodium, per vial <1% 13 $168.33
86677 <1% 14 $158.20
85610 <1% 47 $129.81
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose <1% 15 $85.30
J2550 Injection, promethazine hcl, up to 50 mg <1% 17 $76.15
84550 <1% 16 $63.28
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 12 $61.38
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 13 $47.02
J7050 Infusion, normal saline solution, 250 cc <1% 15 $24.25
94761 <1% 16 $14.35
91300 <1% 489 $1.47
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 0% 551 $0.00
82948 0% 31 $0.00
Q0243 Injection, casirivimab and imdevimab, 2400 mg 0% 12 $0.00
J2704 Injection, propofol, 10 mg 0% 14 $0.00
00000 0% 26 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBARBO, STEVEN (CEO)